98.9%
ravulizumabrituximabNeuromyelitis optica spectrum disorderNMOSD
…vels and low C5 activity, confirming transplacental transfer of ravulizumab. The infant, now 4 months old, remains well.Conclusions This is…
6articles mentioning drugs
15drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Ravulizumab ×
Ravulizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Ravulizumab
6 articles · page 1 of 1ravulizumabmethylprednisolonecyclophosphamideSLElupus pneumonitisAPS
…d APS, refractory to glucocorticoids, successfully treated with ravulizumab, a terminal complement inhibitor.Methods A 30-year-old woman wi…
ravulizumabcrovalimabeculizumabparoxysmal nocturnal haemoglobinuriaNational Institute for Health and Care ExcellenceNICE
…bability of non-inferiority of crovalimab versus eculizumab and ravulizumab.Conclusions Interpretations of statistically non-significant IT…
eculizumabnarsopilmabpegcetacoplanrituximabdefibrotidenomacopanravulizumabJACIE-accredited BMT centrestransfusions
…een put forward for consideration in treating high-risk TA-TMA; eculizumab, narsopilmab, rituximab, defibrotide, ravulizumab, nomacopan, p…
ravulizumabrituximabNeisseria meningitidismeningococcal sepsisneuromyelitis optica spectrum disordervaccinationNMOSD
…ubsequently developed meningococcal sepsis after treatment with ravulizumab, despite prior vaccination; and we propose strategies to manage…
aspirinapixabanravulizumabmiddle cerebral artery stenosisCD59 deficiencymoyamoya-like vasculopathyiron deficiency anaemiahaematology team
…ment complex. After control of her PNH, she was then changed to aspirin only, as protection for her PNH-associated moyamoya-like vascul…